Australian University Rankings Guide

Journal of Neuropathology and Experimental Neurology (ERA Journal)

Journal of Neuropathology and Experimental Neurology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Journal of Neuropathology and Experimental Neurology issns are issn1: 0022-3069 issn2: 1554-6578.

The fields covered by Journal of Neuropathology and Experimental Neurology as part of the evaluation of Australian university research excellence are:

Clinical Sciences Research Rankings (Sub-Field)

Neurosciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Clinical Sciences field include:

- Ageing International: information bulletin of the International Federation on Ageing
- Archives of Pathology and Laboratory Medicine
- Endocrine Journal
- Expert Review of Gastroenterology and Hepatology
- Hormone and Metabolic Research
- Intensive Care Medicine Experimental
- International Journal of Biomedical Science
- International Journal of Hyperthermia
- JAIDS: Journal of Acquired Immune Deficiency Syndromes
- Journal of Cell Communication and Signaling
- Journal of Tissue Engineering and Regenerative Medicine
- Minerva Ortopedica e Traumatologica
- NeuroRehabilitation: an interdisciplinary journal
- Occupational Therapy in Mental Health: a journal of psychosocial practice and research
- Patient Safety in Surgery


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4